Stockreport

Is Denali Therapeutics (DNLI) the Most Promising Mid-Cap Healthcare Stock Under $50? [Yahoo! Finance]

Denali Therapeutics Inc.  (DNLI) 
Last denali therapeutics inc. earnings: 8/6 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.denalitherapeutics.com
PDF On December 11, Wedbush analyst Laura Chico maintained her bullish stance on Denali Therapeutics (NASDAQ:DNLI). She rated the stock Buy with a $30 target price, implyin [Read more]